8 Analysts Assess MaxLinear: What You Need To Know
Portfolio Pulse from Benzinga Insights
MaxLinear (NASDAQ:MXL) has received mixed analyst ratings over the past three months, with a decline in the average 12-month price target. Analysts have adjusted their ratings and price targets, reflecting concerns over MaxLinear's financial health, including a significant revenue decline and below-average profitability metrics.

October 01, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MaxLinear has received mixed analyst ratings, with a decline in the average 12-month price target. Analysts have adjusted their ratings and price targets, reflecting concerns over MaxLinear's financial health, including a significant revenue decline and below-average profitability metrics.
The article highlights a decline in MaxLinear's average price target by 11.7% and mixed analyst ratings, with several analysts lowering their price targets. This reflects concerns over the company's financial health, including a significant revenue decline of 49.99% and below-average profitability metrics. These factors are likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100